Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Grenville Oades"'
Publikováno v:
Urology Case Reports, Vol 51, Iss , Pp 102561- (2023)
A 57-year-old male presented with a 2-month history of a cough, weight loss, chest discomfort and night sweats. He was diagnosed with poor prognosis metastatic Renal Cancer (RCC) according to International Metastatic RCC Database Consortium (IMDC) cr
Externí odkaz:
https://doaj.org/article/b8a46589b20d49999acd11a56f46d130
Autor:
Stephan Ursprung, Helen Mossop, Ferdia A. Gallagher, Evis Sala, Richard Skells, Jamal A. N. Sipple, Thomas J. Mitchell, Anita Chhabra, Kate Fife, Athena Matakidou, Gemma Young, Amanda Walker, Martin G. Thomas, Mireia Crispin Ortuzar, Mark Sullivan, Andrew Protheroe, Grenville Oades, Balaji Venugopal, Anne Y. Warren, John Stone, Tim Eisen, James Wason, Sarah J. Welsh, Grant D. Stewart
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Window-of-opportunity trials, evaluating the engagement of drugs with their biological target in the time period between diagnosis and standard-of-care treatment, can help prioritise promising new systemic treatments for later-pha
Externí odkaz:
https://doaj.org/article/c51c1579691f49dabf5c4459307d8325
Autor:
Michelle Wilson, Naveen S Vasudev, Grant D Stewart, Adebanji Adeyoju, Jon Cartledge, Michael Kimuli, Shibendra Datta, Damian Hanbury, David Hrouda, Grenville Oades, Poulam Patel, Naeem Soomro, Mark Sullivan, Jeff Webster, Peter J Selby, Rosamonde E Banks
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Objectives To describe the frequency and nature of symptoms in patients presenting with suspected renal cell carcinoma (RCC) and examine their reliability in achieving early diagnosis.Design Multicentre prospective observational cohort study.Setting
Externí odkaz:
https://doaj.org/article/6cfcf49e402e4693a956dc28fe5252e7
Autor:
Naeem Soomro, Jan Lecouturier, Deborah D Stocken, Jing Shen, Ann Marie Hynes, Holly F Ainsworth, David Breen, Grenville Oades, David Rix, Michael Aitchison
Publikováno v:
Health Technology Assessment, Vol 21, Iss 81 (2017)
Background: There is uncertainty around the appropriate management of small renal tumours. Treatments include partial nephrectomy, ablation and active surveillance. Objectives: To explore the feasibility of a randomised trial of ablation versus activ
Externí odkaz:
https://doaj.org/article/92bfce2de63045f5aec39796617ac8ac
Autor:
Osman El-Koubani, James Blackmur, Flora Rodgers, Gianluca Maresca, Lucy Drummond, Caroline Bradley, Siobhan Duffy, Satchi Swami, Khalid Janjua, Steve Leung, Ross Clark, Gavin Lamb, Alex Chapman, James Donaldson, Grenville Oades, Alexander Laird
Publikováno v:
Journal of Urology. 209
Autor:
James Peter Blackmur, Etienne Chew, Matthew Trail, Katie Brodie, Nicola Santoni, Flora Rodger, David Hamilton, Fortis Gaba, Sophie Randall, Sarika Nalagatla, Brian Little, Khalid Janjua, Clare Sweeney, Andrew Martindale, Khaver Qureshi, Antony Riddick, Kevin O’Connor, S. Alan McNeill, Simon Phipps, Mark L. Cutress, Edward A. A. Mains, Ian Dunn, Sarah Reid, Grant D. Stewart, Gavin Lamb, Muhammad Zeeshan Aslam, Steve Leung, Ross Clark, Ian Wilson, Grenville Oades, Alexander Chapman, Alexander Laird
Acknowledgements: The authors would like to thank the Uro-oncology multi-disciplinary teams across the various sites involved in the study for their assistance in patient identification.
PURPOSE: Nephroureterectomy(NU) remains the gold-standard
PURPOSE: Nephroureterectomy(NU) remains the gold-standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c91d881b0156991412da08360b8a05
https://www.repository.cam.ac.uk/handle/1810/348484
https://www.repository.cam.ac.uk/handle/1810/348484
Autor:
Khaver N Qureshi, Gerard McCabe, Nkem Umez-Eronini, Grenville Oades, Omar M Aboumarzouk, Dhruv Sahni, Jane Hendry
Publikováno v:
Journal of Clinical Urology. 15:272-276
Introduction: The gold standard treatment for high risk upper tract urothelial cancers is radical nephroureterectomy. Little evidence exists specifically directed for octogenarians with this disease, therefore we highlight our centre’s outcomes and
Autor:
Grant D, Stewart, Sarah J, Welsh, Stephan, Ursprung, Ferdia A, Gallagher, James O, Jones, Jacqui, Shields, Christopher G, Smith, Thomas J, Mitchell, Anne Y, Warren, Axel, Bex, Ekaterini, Boleti, Jade, Carruthers, Tim, Eisen, Kate, Fife, Abdel, Hamid, Alexander, Laird, Steve, Leung, Jahangeer, Malik, Iosif A, Mendichovszky, Faiz, Mumtaz, Grenville, Oades, Andrew N, Priest, Antony C P, Riddick, Balaji, Venugopal, Michelle, Welsh, Kathleen, Riddle, Lisa E M, Hopcroft, Alison, Fielding
Publikováno v:
British journal of cancer. 127(6)
Surgery for renal cell carcinoma (RCC) with venous tumour thrombus (VTT) extension into the renal vein (RV) and/or inferior vena cava (IVC) has high peri-surgical morbidity/mortality. NAXIVA assessed the response of VTT to axitinib, a potent tyrosine
Autor:
Lisa Jayne Ferrie, Flora Rodger, Alvaro Sanchez-Rubio, Matthieu Poyade, Paul M. Rea, Grenville Oades
Publikováno v:
Medical Visualization and Applications of Technology ISBN: 9783031067341
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a081351545b0d0e52ca1d37bc893be73
https://doi.org/10.1007/978-3-031-06735-8_3
https://doi.org/10.1007/978-3-031-06735-8_3
Autor:
Grant D. Stewart, Tim Eisen, Gemma Young, Mark Sullivan, Richard Skells, Sarah J. Welsh, Anne Y. Warren, Amanda Walker, Helen Mossop, Ferdia A. Gallagher, Evis Sala, Balaji Venugopal, Grenville Oades, A. Chhabra, Andrew Protheroe, James Wason, Jamal A. N. Sipple, John Stone, Thomas J. Mitchell, Athena Matakidou, Kate Fife, Stephan Ursprung, Mireia Crispin Ortuzar, Martin G. Thomas
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Funder: AstraZeneca (GB)
Background: Window-of-opportunity trials, evaluating the engagement of drugs with their biological target in the time period between diagnosis and standard-of-care treatment, can help prioritise promising new systemic tr
Background: Window-of-opportunity trials, evaluating the engagement of drugs with their biological target in the time period between diagnosis and standard-of-care treatment, can help prioritise promising new systemic tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629392efc62a5735d8880553cf148d3e